Key result
Newer-generation DES and bioresorbable scaffolds advance coronary stenting to improve clinical outcomes in CAD.
Why the study?
Coronary stent material and design have evolved over 30 years, necessitating an updated focus on their current clinical status.
This review provides an overview of the evolution and current clinical applications of coronary stents.
Novel bioresorbable stent finding is hypothesis-generating; leaves open need for confirmatory randomized trials in CAD.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eun‐Seok Shin (2015) conducted a review in Coronary artery disease. Coronary stents was evaluated. Coronary stents have evolved from bare-metal and early drug-eluting platforms to newer generation drug-eluting stents and bioresorbable scaffolds to improve clinical outcomes in coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: